#weekend_review #mdssm HIGHER-RISK #MDS: A DECADE OF CLINICAL TRIALS

The last decade in HR-MDS has taught us a humbling lesson

Promising biology ≠ successful phase III trial.
Higher response rate ≠ longer survival.

why so many failed, and where we go next. 👇